NeoGenomics, Inc. (NASDAQ:NEO) Q4 2023 Earnings Call Transcript February 20, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.01. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics Fourth Quarter and Full […]
Related Keywords
Chris Smith , Alex Nowak , Jeff Sherman , Circuit Court , Clinical Services , Cambridge United Kingdom , Federal Circuit , Advanced Diagnostics , Breakout Stocks To Buy Right Now , Neogenomics , Nc , Fourth Quarter , Kendra Sweeney , Financial Results , Revenue Cycle Management , Gross Profit ,
comparemela.com © 2020. All Rights Reserved.